DERM
Journey Medical Corp
6.60$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.8% | 73.5% | 70.6% | 71.3% | 72.1% | 60.0% | 63.5% | 63.2% | 66.2% | 70.7% | 71.0% | 74.0% | |
| 37.5% | 35.7% | 36.1% | 36.7% | 35.1% | 25.3% | 24.8% | 25.0% | 29.3% | 25.5% | 29.7% | 26.1% | |
| 37.5% | 35.7% | 36.1% | 36.7% | 35.1% | 25.3% | 24.8% | 25.0% | 29.3% | 25.5% | 29.7% | 26.1% | |
| 12.1% | 19.8% | 14.7% | 16.1% | 16.7% | 12.8% | 21.2% | 19.3% | 21.1% | 31.5% | 27.3% | 36.9% | |
| 16.7% | 13.3% | 15.9% | 14.9% | 18.4% | 18.0% | 14.7% | 15.8% | 13.9% | 10.2% | 10.2% | 8.3% | |
| 32.0% | 26.4% | 29.3% | 28.6% | 27.9% | 39.7% | 36.2% | 36.6% | 33.7% | 29.2% | 28.9% | 25.9% | |
| 73.6% | 73.5% | 80.5% | 82.7% | 82.9% | 75.0% | 74.6% | 76.3% | 69.6% | 66.3% | 66.3% | 67.3% | |
| 73.6% | 54.5% | 58.5% | 52.4% | 52.0% | 43.8% | 47.3% | 49.9% | 46.6% | 39.6% | 41.3% | 46.5% | |
| 4.7% | 4.0% | 4.6% | 4.7% | 2.0% | 0.9% | 2.3% | 4.7% | 6.7% | 0.1% | 2.8% | 5.2% | |
| 44.4% | 20.9% | 20.9% | 22.4% | 24.0% | 20.0% | 17.0% | 15.7% | 13.6% | 9.4% | 9.5% | 8.2% | |
| – | 19.0% | 22.1% | 30.3% | 30.9% | 31.0% | 27.2% | 26.3% | 22.9% | 26.7% | 25.0% | 20.8% | |
| 26.4% | 26.5% | 19.5% | 17.3% | 17.1% | 25.0% | 25.4% | 23.7% | 30.4% | 33.7% | 33.7% | 32.7% | |
| -106.5% | -94.2% | -124.4% | -132.2% | -138.3% | -108.5% | -107.2% | -116.9% | -114.1% | -104.1% | -110.0% | -102.7% | |
| 31.9% | 25.1% | 29.7% | 30.7% | 32.1% | 27.6% | 26.6% | 28.7% | 29.3% | 25.9% | 29.8% | 28.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.